{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:42:19Z","timestamp":1794584539166,"version":"4.9.1"},"reference-count":18,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.3892\/ol.2013.1565","type":"journal-article","created":{"date-parts":[[2013,9,6]],"date-time":"2013-09-06T09:31:54Z","timestamp":1378459914000},"page":"1492-1498","source":"Crossref","is-referenced-by-count":35,"title":["Inhibitory effect of valproic acid on bladder cancer in combination with chemotherapeutic agents in vitro and in vivo"],"prefix":"10.3892","volume":"6","author":[{"given":"DEGUI","family":"WANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUHONG","family":"JING","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SIWEI","family":"OUYANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BEI","family":"LIU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TIANYUAN","family":"ZHU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HAITAO","family":"NIU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YINGXIA","family":"TIAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2013,9,6]]},"reference":[{"key":"key20180108105811_b1-ol-06-05-1492","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.urolonc.2009.07.025","article-title":"Targeted therapies in non-muscle-invasive bladder cancer according to the signaling pathways","volume":"29","author":"Wallerand","year":"2011","journal-title":"Urol Oncol"},{"key":"key20180108105811_b2-ol-06-05-1492","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/092986712798918842","article-title":"Multi-targeted histone deacetylase inhibitors in cancer therapy","volume":"19","author":"Ai","year":"2012","journal-title":"Curr Med Chem"},{"key":"key20180108105811_b3-ol-06-05-1492","doi-asserted-by":"crossref","first-page":"315939","DOI":"10.1155\/2011\/315939","article-title":"Rationale for possible targeting of histone deacetylase signaling in cancer diseases with a special reference to pancreatic cancer","volume":"2011","author":"Oua\u00efssi","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"key20180108105811_b4-ol-06-05-1492","doi-asserted-by":"crossref","first-page":"898","DOI":"10.2174\/156800910793358014","article-title":"Histone deacetylases: anti-angiogenic targets in cancer therapy","volume":"10","author":"Mottet","year":"2010","journal-title":"Curr Cancer Drug Targets"},{"key":"key20180108105811_b5-ol-06-05-1492","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.canlet.2009.02.027","article-title":"Histone deacetylase inhibitors as a new weapon in the arsenal of differentiation therapies of cancer","volume":"280","author":"Botrugno","year":"2009","journal-title":"Cancer Lett"},{"key":"key20180108105811_b6-ol-06-05-1492","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0301-0082(82)90010-7","article-title":"Mechanism of anticonvulsant action of valproate","volume":"19","author":"Chapman","year":"1982","journal-title":"Prog Neurobiol"},{"key":"key20180108105811_b7-ol-06-05-1492","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2490-12-21","article-title":"Valproic acid decreases urothelial cancer cell proliferation and induces thrombospondin-1 expression","volume":"12","author":"Byler","year":"2012","journal-title":"BMC Urol"},{"key":"key20180108105811_b8-ol-06-05-1492","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1158\/1541-7786.MCR-10-0471","article-title":"Low-dose valproic acid enhances radiosensitivity of prostate cancer through acetylated p53-dependent modulation of mitochondrial membrane potential and apoptosis","volume":"9","author":"Chen","year":"2011","journal-title":"Mol Cancer Res"},{"key":"key20180108105811_b9-ol-06-05-1492","first-page":"97","article-title":"Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE(2)-C cells by valproic acid: enhancement by combination with interferon-alpha","volume":"20","author":"Cinatl","year":"2002","journal-title":"Int J Oncol"},{"key":"key20180108105811_b10-ol-06-05-1492","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1158\/1535-7163.MCT-08-1076","article-title":"Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivo","volume":"8","author":"Kortenhorst","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"key20180108105811_b11-ol-06-05-1492","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3748\/wjg.v13.i2.250","article-title":"Antiproliferation and apoptosis induction of paeonol in HepG2 cells","volume":"13","author":"Xu","year":"2007","journal-title":"World J Gastroenterol"},{"key":"key20180108105811_b12-ol-06-05-1492","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1210\/jc.2004-1355","article-title":"Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells","volume":"90","author":"Catalano","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180108105811_b13-ol-06-05-1492","first-page":"248","article-title":"The effects of the histone deacetylase inhibitor valproic acid on cell cycle, growth suppression and apoptosis in multiple myeloma","volume":"91","author":"Kaiser","year":"2006","journal-title":"Haematologica"},{"key":"key20180108105811_b14-ol-06-05-1492","doi-asserted-by":"crossref","DOI":"10.1007\/s40291-013-0048-1","article-title":"Monitoring survivin expression in cancer: implications for prognosis and therapy","author":"Guindalini","year":"2013","journal-title":"Mol Diagn Ther"},{"key":"key20180108105811_b15-ol-06-05-1492","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4236\/jct.2013.46A3001","article-title":"Intravesical treatment with vorinostat can prevent tumor progression in MNU induced bladder cancer","volume":"4","author":"Wang","year":"2013","journal-title":"J Cancer Ther"},{"key":"key20180108105811_b16-ol-06-05-1492","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.1158\/0008-5472.CAN-05-4048","article-title":"Synergistic induction of folate receptor beta by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: mechanism and utility in enhancing selective growth inhibition by antifolates","volume":"66","author":"Qi","year":"2006","journal-title":"Cancer Res"},{"key":"key20180108105811_b17-ol-06-05-1492","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1182\/blood-2005-09-008086","article-title":"Antileukemia activity of the combination of an anthracycline with a histone deacetylase inhibitor","volume":"108","author":"Sanchez-Gonzalez","year":"2006","journal-title":"Blood"},{"key":"key20180108105811_b18-ol-06-05-1492","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cncr.21552","article-title":"The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemia","volume":"106","author":"Kuendgen","year":"2006","journal-title":"Cancer"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2013.1565\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T14:41:02Z","timestamp":1515422462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2013.1565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,6]]},"references-count":18,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,9,6]]},"published-print":{"date-parts":[[2013,11]]}},"alternative-id":["10.3892\/ol.2013.1565"],"URL":"https:\/\/doi.org\/10.3892\/ol.2013.1565","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,6]]}}}